[在社区获得的肺炎中使用生物标志物指导的抗生素管理]
Ruud Duijkers1, Marc J M Bonten1, Wim G Boersma1,2
1x.
Nederlands tijdschrift voor geneeskunde
|May 20, 2025
概括
使用C反应蛋白 (CRP) 或前素 (PCT) 的生物标志物导向治疗显著减少了社区获得性肺炎 (CAP) 患者的抗生素持续时间. 这种方法提供了一种安全有效的方法来缩短抗生素疗程,而不会影响临床结果.
科学领域:
- 传染性疾病 传染性疾病
- 临床微生物学 临床微生物学
- 生物标志物 生物标志物
背景情况:
- 社区获得性肺炎 (CAP) 是一种常见的感染,需要抗生素治疗.
- 优化抗生素持续时间对于打击抗菌素耐药性和减少副作用至关重要.
- 像CRP和PCT这样的生物标志物可以帮助指导抗生素治疗决策.
研究的目的:
- 评估生物标记指导的算法是否可以缩短非重症监护室 (ICU) CAP患者的抗生素治疗时间.
- 为了比较前素 (PCT) 和C反应蛋白 (CRP) 的疗效,指导治疗与标准护理相比.
主要方法:
- 一项随机控制的多中心研究,涉及468名非ICU CAP患者.
- 患者在2-3天后被随机分配到标准治疗,PCT引导或CRP引导的组.
- 主要结局:30天内的抗生素日数;次要结局:新处方,稳定时间,住院,死亡率.
主要成果:
- 抗生素治疗的持续时间在CRP组减少了30% (4 vs. 7天),在PCT组减少了22% (5.5 vs. 7天).
- 两个生物标志物指导小组都显示出抗生素治疗日数的统计显著减少 (p < 0.001).
- 在二次结果 (包括死亡率) 中,两组之间没有发现显著差异.
结论:
- 使用CRP和PCT的生物标记指导算法有效地减少非ICU CAP患者的抗生素持续时间.
- 这种方法允许更短的抗生素疗程,而不会影响患者的安全或临床结果.
- 生物标志物指导治疗是优化在CAP管理中的抗生素使用的有价值策略.
更多相关视频
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
6.8K
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
32.8K
相关概念视频
Pneumonia IV: Management
282
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
282
Pneumonia III: Complications and Assessment
135
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
135
Pneumonia V: Nursing management and Prevention
1.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.8K
Pneumonia I: Introduction
201
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
201
Antibiotic Selection
52.1K
Overview
52.1K
Pulmonary Tuberculosis V
159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
